Clearview Wealth Advisors LLC Viatris Inc Transaction History

Clearview Wealth Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$8.72 - $11.56 $113 - $150	-13 Reduced 68.42%	6 $0
Q1 2022 Apr 29, 2022	SELL	$9.81 - $15.4 $133,337 - $209,316	-13,592 Reduced 99.86%	19 $0
Q4 2021 Feb 02, 2022	BUY	$12.09 - $14.68 $7,955 - $9,659	658 Added 5.08%	13,611 $184,000
Q3 2021 Nov 02, 2021	BUY	$13.25 - $15.13 $8,082 - $9,229	610 Added 4.94%	12,953 $176,000
Q2 2021 Jul 30, 2021	BUY	$12.97 - $16.15 $181 - $226	14 Added 0.11%	12,343 $176,000
Q1 2021 May 06, 2021	BUY	$13.59 - $18.54 $167,551 - $228,579	12,329 New	12,329 $172,000

1,141

988M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $11.1B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Clearview Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Clearview Wealth Advisors LLC with notifications on news.